Latest paper led by Rui Moura, collab with @AnnedesRieux @UCLouvain_be now @JCRnEDITORS. Lipid nanocapsules with retinoic acid significantly reduced disease severity and attenuated demyelination in encephalomyelitis model.
doi.org/10.1016/j.jc...
#MultipleSclerosis #i3SPapers
First paper published in 2026 is out and is a blast! We show that CD44v6-targeted irinotecan nanoparticles + anti-PD-L1 immunotherapy considerably enhance tumor suppression in vivo. Work led by @AnaBaião, now online in @JCRnEDITORS doi.org/10.1016/j.jc...
#i3SPapers #Nanomedicine @CRS_FG_NANO
Our latest paper @DDTReMedia explores multidrug nanosystems for hard-to-treat #Glioblastoma, highlighting rational design, simultaneous/sequential delivery, active targeting and stimuli-responsivess. Led by Catarina Pacheco with @uminho.bsky.social
link.springer.com/article/10.1...
#i3SPapers
Using our 3D intestinal inflamed model, we validated a new therapeutic strategy of mesalazine-loaded chitosan/alginate nanoparticles to effectively reduced the pro-inflammatory state. Collaboration with @Unesp now online in @CarbohydratePolymers
doi.org/10.1016/j.ca...
#Genegut #i3Spapers
Before taking our first steps toward developing an advanced 3D bladder tumor model (stay tuned!), we carried out an in-depth review to map the state of the art and key challenges and opportunities @ActaBiomaterialia
www.sciencedirect.com/science/arti...
#BladderCancer #3DModels #i3Spapers
Particularly proud of this review paper @DDTReMedia by @Cespu pharmacy student Eva Morim, supervised by Catarina Pacheco on how intranasal drug delivery and nanocarrier-based systems can help bypass the BBB for treating neurological disorders.
link.springer.com/article/10.1... #i3SPapers
Take a look on our recent paper at @JCREditors and learn how IBD-specific stimuli can be used to design smarter and more precise nanotherapies. Discover how disease hallmarks can guide drug delivery.
#i3SPapers #nanomedicines #IBD
doi.org/10.1016/j.jc...
A team of #i3S researchers has uncovered a mechanism that ensures a precise chromosome separation during #celldivision.
Team leader Carlos Conde and researcher Nelson Leça detail the implications of this discovery.
#i3Snews #i3Sresearch #i3Spapers #cancer #cancerresearch
Our latest study on IBD presents an oxidative-responsive #nanomedicine for oral delivery of budesonide. Penetrates mucus, sheds its PEG corona in inflamed colon tissue and releases budesonide at target site. Now online
@JCRnEDITORS
#i3SPapers @crohnscolitisfdn.bsky.social
doi.org/10.1016/j.jc...
🚨New strategy against glioblastoma! Targeted nanoparticle for dual delivery of anti-angiogenic + glycolysis inhibitor, via intranasal route🧠
Led by Catarina Pacheco, collaboration with @icvs_uminho
and @SaludISCIII, now online @JCRnEDITORS
@i3suporto.bsky.social #i3SPapers
shre.ink/eky7
A team of #i3S researchers has uncovered a mechanism that ensures a precise chromosome separation during #celldivision.
The finding can pave the way to the development of new therapies to treat faulty cell division-derived conditions, such as #cancer.
#i3Snews #i3Sresearch #i3Spapers #cancerresearch
In collaboration with @uspoficial.bsky.socialwe established a novel sensory neuron-integrated skin spheroid model for screening biological activity in neuronal pathways. Now online at ACS Biomaterials Science & Engineering. @pubs.acs.org #i3SPapers
pubs.acs.org/doi/full/10....
New paper⬇️
#i3Spapers #i3Sresearch
Mesmerizing 😍
#i3Spapers #i3Sresearch
#i3S researchers Gabriel Oliveira and Tânia Silva feature in a video intro in which they discuss their work and how they carried out the research featured in a paper recently published.
📺👀👇
#i3Sresearch #i3Spapers